⌘K

Home/Filings/4/0001382963-19-000020

4//SEC Filing

Doyle Noah 4

Accession 0001382963-19-000020

CIK 0001460702other

View on SEC.gov Company Profile

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 4:23 PM ET

Size

5.3 KB

Accession

0001382963-19-000020

Insider Transaction Report

Form 4

Period: 2019-02-06

RITTER PHARMACEUTICALS INCRTTR

Director

Transactions

Award
Non-qualified Stock Option (right to buy)
2019-02-06+15,000→ 15,000 total
Exercise: $0.60Exp: 2029-02-06→ Common Stock (15,000 underlying)

Footnotes (1)

[F1]The option vests in twelve (12) equal monthly installments beginning on March 6, 2019 with the balance vesting on the 6th day of each calendar month thereafter until vested in full.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

RITTER PHARMACEUTICALS INC

CIK 0001460702

Entity typeother

Related Parties

1

filerCIK 0001631673

Filing Metadata

Form type: 4
Filed: Feb 7, 7:00 PM ET
Accepted: Feb 8, 4:23 PM ET
Size: 5.3 KB

View on SEC.gov